We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$7.75B
AUM Growth
+$180M
Cap. Flow
-$55.1M
Cap. Flow %
-0.71%
Top 10 Hldgs %
15.53%
Holding
560
New
192
Increased
91
Reduced
96
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Industrials 15.13%
3 Healthcare 14.64%
4 Financials 8.83%
5 Consumer Discretionary 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
351
Parker-Hannifin
PH
$135B
$1.43M 0.02%
+8,405
New +$1.45M
AWI icon
352
Armstrong World Industries
AWI
$7.84B
$1.42M 0.02%
14,590
-5,688
-28% -$509K
KRTX
353
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.41M 0.02%
+70,160
New +$1.4M
PSNL icon
354
Personalis
PSNL
$1.51B
$1.36M 0.02%
+50,095
New +$1.42M
HD icon
355
Home Depot
HD
$355B
$1.28M 0.02%
+6,174
New +$1.23M
AKRO
356
DELISTED
Akero Therapeutics
AKRO
$1.24M 0.02%
+64,688
New +$1.23M
CMBM
357
DELISTED
Cambium Networks
CMBM
$1.2M 0.02%
+125,000
New +$1.2M
MORF
358
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.19M 0.02%
+60,213
New +$1.14M
BSX icon
359
Boston Scientific
BSX
$71.5B
$1.18M 0.02%
+27,357
New +$1.05M
GNCA
360
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.16M 0.02%
+296,062
New +$1.54M
SWAV
361
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$1.14M 0.01%
20,030
-50,182
-71% -$2.44M
GMDA
362
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$1.12M 0.01%
+221,229
New +$1.74M
MU icon
363
Micron Technology
MU
$991B
$1.02M 0.01%
26,395
-452,672
-94% -$17.2M
TW icon
364
Tradeweb Markets
TW
$21.6B
$980K 0.01%
+22,380
New +$934K
SHSP
365
DELISTED
SharpSpring, Inc.
SHSP
$975K 0.01%
+75,073
New +$1.26M
NEX
366
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$973K 0.01%
+144,777
New +$1.35M
CFRX
367
CALL
DELISTED
ContraFect Corporation
CFRX
$957K 0.01%
2,344
COHR icon
368
Coherent
COHR
$74.2B
$944K 0.01%
25,821
+5,553
+27% +$203K
ACR
369
ACRES Commercial Realty
ACR
$108M
$933K 0.01%
27,492
+13,596
+98% +$450K
SYRS
370
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$926K 0.01%
+10,000
New +$696K
BCEL
371
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$925K 0.01%
+49,095
New +$886K
CYPH
372
CALL
Cypherpunk Technologies Inc
CYPH
$73.3M
$921K 0.01%
51,429
PHAS
373
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$893K 0.01%
+68,054
New +$834K
NPTN
374
DELISTED
NEOPHOTONICS CORP
NPTN
$869K 0.01%
+207,818
New +$1.1M
VICR icon
375
Vicor
VICR
$10.2B
$865K 0.01%
+27,845
New +$895K

Similar funds

Alyeska Investment Group's Q2 2019 Portfolio in Review

As of Q2 2019, Alyeska Investment Group held 560 positions worth $7.75B, up 2.4% from $7.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group's Q2 2019 filing shows 192 new, 91 increased, 96 reduced and 133 closed positions. Its largest new stake was Uber: 2,870,924 shares worth $133M. The largest sale was Intel, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Alyeska Investment Group's largest Q2 2019 buy was Uber: 2,870,924 shares worth $133M.
  • Alyeska Investment Group added most to NXP Semiconductors in Q2 2019, an estimated $91M increase.
  • Alyeska Investment Group's biggest Q2 2019 reduction was Activision Blizzard, cutting an estimated $64.8M.
  • Alyeska Investment Group fully exited Intel in Q2 2019, selling an estimated $143M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $7.75B portfolio in Q2 2019.
  • Alyeska Investment Group opened 192 new positions and closed 133 in Q2 2019.
  • Alyeska Investment Group's portfolio value rose 2.4% quarter-over-quarter to $7.75B.

Based on Alyeska Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.